Joseph J. Schildkraut
#103,946
Most Influential Person Now
Joseph J. Schildkraut's AcademicInfluence.com Rankings
Download Badge
Biology
Joseph J. Schildkraut's Degrees
- Doctorate Medicine Harvard University
Why Is Joseph J. Schildkraut Influential?
(Suggest an Edit or Addition)Joseph J. Schildkraut's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- The catecholamine hypothesis of affective disorders: a review of supporting evidence. (1965) (2941)
- Biogenic Amines and Emotion (1967) (831)
- The catecholamine hypothesis of affective disorders. A review of supporting evidence. (1967) (552)
- Metabolism of normetanephrine-H3 in rat brain--identification of conjugated 3-methoxy-4-hydrophenylglycol as the major metabolite. (1968) (350)
- Alterations in brain norepinephrine metabolism induced by environmental stimuli previously paired with inescapable shock. (1980) (265)
- The dexamethasone suppression test: An overview of its current status in psychiatry (1987) (247)
- Toward a biochemical classification of depressive disorders. I. Differences in urinary excretion of MHPG and other catecholamine metabolites in clinically defined subtypes of depressions. (1978) (205)
- Norepinephrine metabolites as biochemical criteria for classifying depressive disorders and predicting responses to treatment: preliminary findings. (1973) (199)
- Catecholamine metabolism in affective disorders—III (1970) (189)
- Clozapine for comorbid substance use disorder and schizophrenia: do patients with schizophrenia have a reward-deficiency syndrome that can be ameliorated by clozapine? (1999) (178)
- Neuropsychopharmacology and the Affective Disorders (1969) (164)
- Toward a biochemical classification of depressive disorders (1981) (154)
- Amitriptyline in the Treatment of Anorexia Nervosa: A Double‐Blind, Placebo‐Controlled Study (1985) (151)
- Some biochemical correlates of panic attacks with agoraphobia and their response to a new treatment. (1984) (145)
- The effects of psychoactive drugs on norepinephrine-3-H metabolism in brain. (1967) (145)
- Amphetamine withdrawal: affective state, sleep patterns, and MHPG excretion. (1972) (137)
- Catecholamine metabolism in affective disorders. I. Normetanephrine and VMA excretion in depressed patients treated with imipramine. (1965) (135)
- Norepinephrine metabolism and drugs used in the affective disorders: a possible mechanism of action. (1967) (132)
- Norepinephrine Turnover and Metabolism in Rat Brain after Long-Term Administration of Imipramine (1970) (122)
- The effects of lithium ion on H3-norepinephrine metabolism in brain. (1966) (109)
- Neuropharmacology of the affective disorders. (1973) (106)
- Biogenic amines and affective disorders. (1974) (105)
- The effects of pentobarbital on the fate of intracisternally administered norepinephrine-H3. (1967) (103)
- Reduced platelet monoamine oxidase activity in a subgroup of schizophrenic patients. (1976) (94)
- Antipsychotic medication, prolactin elevation, and ovarian function in women with schizophrenia and schizoaffective disorder (2002) (91)
- Hypomanic reactions to ACTH and prednisone treatment for multiple sclerosis (1988) (89)
- Toward a biochemical classification of depressive disorders, VII: urinary free cortisol and urinary MHPG in depressions. (1983) (81)
- Changes in norepinephrine turnover in rat brain during chronic administration of imipramine and protriptyline: a possible explanation for the delay in onset of clinical antidepressant effects. (1971) (77)
- CLINICAL EXPERIENCE WITH DIHYDROXYPHENYLALANINE (DOPA) IN DEPRESSION. (1963) (76)
- MHPG Excretion in Depressive Disorders: Relation to Clinical Subtypes and Desynchronized Sleep (1973) (72)
- Toward a biochemical classification of depressive disorders. II. Application of multivariate discriminant function analysis to data on urinary catecholamines and metabolites. (1978) (71)
- Mind and mood in modern art, II: Depressive disorders, spirituality, and early deaths in the abstract expressionist artists of the New York School. (1994) (71)
- Clozapine response and plasma catecholamines and their metabolites (1993) (69)
- Effects of 6-Hydroxydopamine on Sleep in the Rat (1971) (68)
- Toward a biochemical classification of depressive disorders, V: Heterogeneity of unipolar depressions. (1982) (67)
- Toward a biochemical classification of depressive disorders. X. Urinary catecholamines, their metabolites, and D-type scores in subgroups of depressive disorders. (1989) (66)
- Diurnal variation of plasma cortisol and homovanillic acid in healthy subjects (1996) (64)
- Catecholamine metabolism in affective disorders. II. Norepinephrine, normetanephrine, epinephrine, metanephrine, and VMA excretion in hypomanic patients. (1969) (63)
- Effects of tricyclic antidepressants on the uptake and mabolism of intracisternally administered norepinephrine-H3 in rat brain. (1969) (61)
- Effects of psychoactive drugs on the metabolism of intracisternally administered serotonin in rat brain. (1969) (60)
- EXCRETION OF 3-METHOXY-4-HYDROXYMANDELIC ACID (VMA) IN DEPRESSED PATIENTS TREATED WITH ANTIDEPRESSANT DRUGS. (1964) (58)
- MHPG as a predictor of antidepressant response to imipramine and maprotiline. (1980) (55)
- Amphetamine withdrawal: depression and M.H.P.G. excretion. (1971) (53)
- Differences in platelet monoamine oxidase activity in subgroups of schizophrenic and depressive disorders. (1978) (51)
- THE EFFECTS OF LITHIUM ON NOREPINEPHRINE TURNOVER AND METABOLISM: BASIC AND CLINICAL STUDIES (1974) (49)
- Normetanephrine excretion and affective state in depressed patients treated with imipramine. (1966) (48)
- M.H.P.G. excretion and clinical classification in depressive disorders. (1973) (48)
- Effects of short-and long-term administration of tricyclic antidepressants and lithium on norepinephrine turnover in brain. (1976) (47)
- Toward a rapidly acting antidepressant: the normetanephrine and extraneuronal monoamine transporter (uptake 2) hypothesis. (2004) (43)
- Alterations in brain norepinephrine metabolism and behavior induced by environmental stimuli previously paired with inescapable shock (1981) (43)
- Should Clozapine Be a First‐line Treatment for Schizophrenia? The Rationale for a Double‐Blind Clinical Trial in First‐Episode Patients (1995) (41)
- Tranylcypromine: effects on norepinephrine metabolism in rat brain. (1970) (40)
- Haloperidol response and plasma catecholamines and their metabolites (1993) (39)
- Catecholamine metabolism in affective disorders. IV. Preliminary studies of norepinephrine metabolism in depressed patients treated with amitriptyline. (1972) (39)
- Effects of acute and chronic administration of desmethylimipramine on the content of norepinephrine and other monoamines in the rat brain. (1973) (38)
- Rapid antidepressant response to alprazolam in depressed patients with high catecholamine output and heterologous desensitization of platelet adenylate cyclase (1988) (37)
- Focal cerebral perfusion defects demonstrated by 99mTc-hexamethylpropyleneamine oxime SPECT in elderly depressed patients (1996) (37)
- The catecholamine hypothesis of affective disorders: a review of supporting evidence. 1965. (1995) (36)
- Heterogeneity in anorexia nervosa (1986) (36)
- Elevated platelet MAO activity in schizophrenia-related depressive disorders. (1978) (36)
- Sodium inhibits both adenylate cyclase and high-affinity 3H-labeled p-aminoclonidine binding to alpha 2-adrenergic receptors in purified human platelet membranes. (1982) (35)
- Platelet MAO activity: relationships to clinical and psychometric variables. (1980) (34)
- Hypothalamic-pituitary-adrenal axis activity and 1-year outcome in depression (1993) (33)
- Toward a biochemical classification of depressive disorders, VI: Platelet MAO activity and clinical symptoms in depressed patients. (1982) (33)
- Pharmacology—The Effects of Lithium on Biogenic Amines (1973) (32)
- BIOCHEMICAL DISCRIMINATION OF SUBTYPES OF DEPRESSIVE DISORDERS (1979) (30)
- BIOCHEMICAL AND PRESSOR EFFECTS OF ORAL d, l‐DIHYDROXYPHENYLALANINE IN PATIENTS PRETREATED WITH ANTIDEPRESSANT DRUGS * (1963) (30)
- Changes in norepinephrine output following light therapy for fall/winter seasonal depression (1992) (30)
- Norepinephrine Pools in Rat Brain: Differences in Turnover Rates and Pathways of Metabolism (1971) (29)
- Urinary mhpg in anorexia nervosa patients with and without a concomitant major depressive disorder. (1984) (29)
- The effects of acute and chronic administration of morphine on norepinephrine turnover in rat brain regions. (1977) (28)
- Catecholamine metabolism in affective disorders. 3. MHPG and other catecholamine metabolites in patients treated with lithium carbonate. (1970) (28)
- The effects of lithium salts on the turnover and metabolism of norepinephrine in rat brain (2004) (28)
- Clozapine reduces alcohol drinking in Syrian golden hamsters (2004) (26)
- Platelet MAO activity in anorexia nervosa patients with and without a major depressive disorder. (1984) (25)
- Learned helplessness and urinary MHPG levels in unipolar depression. (1992) (24)
- Platelet monoamine oxidase activity in subgroups of schizophrenic disorders. (1980) (24)
- Cortisol feedback effects on plasma corticotropin levels in healthy subjects (1997) (23)
- Platelet MAO activity and the dexamethasone suppression test in depressed patients. (1983) (23)
- The effects of acute and chronic administration of tricyclic antidepressants on MHPG-SO4 in rat brain. (1977) (23)
- Acute and delayed effects of corticotropin-releasing hormone on dopamine activity in man (1994) (23)
- Amphetamine withdrawal: Effects on threshold of intracranial reinforcement (2004) (23)
- Enhanced signal transduction by adenylate cyclase in platelet membranes of patients showing antidepressant responses to alprazolam: preliminary data. (1985) (22)
- Eminent Creativity, Everyday Creativity, and Health (1999) (22)
- Determination of urinary normetanephrine and metanephrine by radial-compression liquid chromatography and electrochemical detection. (1983) (21)
- Hypothalamic–pituitary–adrenal axis effects on plasma homovanillic acid in man (1999) (21)
- Psychotic and nonpsychotic depressions: II. platelet MAO activity, plasma catecholamines, cortisol, and specific symptoms (1987) (20)
- Toward a biochemical classification of depressive disorders--VIII. Platelet monoamine oxidase activity in subtypes of depressions. (1985) (19)
- Enhanced norepinephrine output during long-term desipramine treatment: a possible role for the extraneuronal monoamine transporter (SLC22A3). (2008) (19)
- Guidelines for therapeutic monitoring of tricyclic antidepressant plasma levels. (1979) (19)
- A biopsychosocial approach to treating patients with affective disorders. (1987) (18)
- Biochemical criteria for classifying depressive disorders and predicting responses to pharmacotherapy: preliminary findings from studies of norepinephrine metabolism. Contributions to biochemistry. (1974) (18)
- CATECHOLAMINE METABOLISM AND AFFECTIVE DISORDERS: STUDIES OF MHPG EXCRETION (1974) (17)
- Toward a Biochemical Classification of Depressive Disorders IX (1985) (17)
- Desynchronized sleep and MHPG excretion: an inverse correlation. (1973) (17)
- Effects of Tricyclic Antidepressants on Norepinephrine Metabolism: Basic and Clinical Studies (1971) (15)
- Toward a biochemical classification of depressive disorders IV: Pretreatment urinary MHPG levels as predictors of antidepressant response to imipramine. (1980) (15)
- Urinary 3-methoxy-4-hydroxyphenylglycol and the depression-type score as predictors of differential responses to antidepressants. (1991) (15)
- Behavioral Effects of Centrally Administered 6-Hydroxydopamine (1972) (14)
- Abnormal flash visual evoked response in melancholia: A replication study (1992) (14)
- Abnormal visual evoked response in melancholia (1989) (12)
- The effects of acute and chronic morphine administration on the levels of 3-methoxy-4-hydroxphenylglycol sulfate in rat brain. (1975) (12)
- BIOCHEMICAL DISCRIMINATION OF SUBGROUPS OF DEPRESSIVE DISORDERS BASED ON DIFFERENCES IN CATECHOLAMINE METABOLISM (1982) (12)
- Beyond Reason: Art and Psychosis: Works From the Prinzhorn Collection (2000) (12)
- The effects of Δ9-tetrahydrocannabinol on the metabolism of norepinephrine in rat brain (2004) (11)
- Pretreatment urinary MHPG levels as predictors of antidepressant responses to alprazolam. (1985) (11)
- Catecholamine measures for diagnosis and treatment of patients with depressive disorders. (1980) (11)
- Platelet monoamine oxidase activity and deficit syndrome schizophrenia (1995) (11)
- Circadian rhythms ofMacaca mulatta: Sleep, EEG, body and eye movement, and temperature (1972) (11)
- Possible pathophysiological mechanisms in subtypes of unipolar depressive disorders based on differences in urinary MHPG levels [proceedings]. (1981) (11)
- Catecholamine metabolism during heroin use. (1977) (11)
- The effects of delta-9-tetrahydrocannabinol on the metabolism of norepinephrine in rat brain. (1971) (10)
- Further studies of the effects of morphine on the levels of MHPG-SO4 in rat brain (1979) (10)
- Rembrandt by Himself (1999) (10)
- Norepinephrine metabolism and psychoactive drugs in the endogenous depressions. 1968. (1968) (10)
- Depression and the spiritual in modern art : homage to Miró (1996) (10)
- Norepinephrine metabolism in the rat brain following acute and chronic administration of thyrotropin releasing hormone (1974) (9)
- Madness and Art: The Life and Works of Adolf Wölfli (1995) (9)
- Increased Gsα within blood cell membrane lipid microdomains in some depressive disorders: an exploratory study. (2013) (9)
- Catecholamine metabolism and affective disorders (1973) (9)
- My Father and I (1959) (8)
- Clinical utility of tricyclic antidepressant blood levels: a case report. (1979) (8)
- Effects of the d- and l-isomers of amphetamine on the levels of 3-methoxy-4-hydroxyphenylglycol sulfate in whole rat brain and rat brain regions. (1978) (8)
- LATE FEEDBACK EFFECTS OF HYPOTHALAMIC–PITUITARY–ADRENAL AXIS HORMONES IN HEALTHY SUBJECTS (1998) (7)
- 7 – Relationship between Psychiatric Diagnostic Groups of Depressive Disorders and MHPG* (1983) (7)
- Urinary MHPG and clinical symptoms in patients with unipolar depression (1994) (7)
- Alpha-methylparatyrosine and sleep in the rat (2004) (7)
- Antidepressants and Related Drugs (1971) (7)
- NOREPINEPHRINE OUTPUT AND METABOLISM IN DEPRESSED PATIENTS DURING ANTIDEPRESSANT TREATMENTS (1992) (7)
- The effects of tranylcypromine isomers on norepinephrine-H3 metabolism in rat brain (2004) (7)
- Norepinephrine Metabolism in Depressive Disorders: Implications for a Biochemical Classification of Depressions (1978) (6)
- Then Melancholy, Now Depression: A Modern Interpretation of Rembrandt's Mental State in Midlife (2007) (6)
- Norepinephrine content of various rat organs after chronic administration of desmethylimipramine. (1975) (6)
- 531 Effects of clozapine on cognitive functions in treatment-refractory schizophrenia (1997) (6)
- Neurochemical studies of the affective disorders: the pharmacological bridge. (1970) (5)
- Mind and Mood in Modern Art I: Miro and "Melancolie" (1995) (5)
- The effects of heroin on catecholamine metabolism in man. (1975) (5)
- The dexamethasone suppression test (DST) and platelet monoamine oxidase (MAO) activity as predictors of psychosis in depression (1986) (5)
- Platelet monoamine oxidase activity in psychiatric disorders: the application of a technique for the isolation of free platelet mitochondria from relatively small blood samples. (1981) (5)
- An improved method for the recovery of mitochondrial monoamine oxidase from human platelets using colchicine and nitrogen decompression. (1981) (5)
- Alpha-methylparatyrosine and sleep in the rat (2004) (4)
- Affective disorders and norepinephrine pharmacology. (1969) (4)
- Norepinephrine metabolism after short- and long-term administration of tricyclic antidepressant drugs and electroconvulsive shock. (1975) (4)
- Amphetamine withdrawal: effects on brain levels of MHPG-SO4 in the rat. (1979) (4)
- Properties of catechol-O-methyl transferase in soluble and particulate preparations from rat red blood cells. (1976) (4)
- Saint Jerome in a dark chamber: Rembrandt's metaphoric portrayal of the depressed mind. (2004) (4)
- Turnover and metabolism of norepinephrine in rat brain after 72 hours on a D-deprivation island (2004) (4)
- Opiates, catecholamines, behavior, and mood (1978) (3)
- The biochemical discrimination of subtypes of depressive disorders: an outline of our studies on norepinephrine metabolism and psychoactive drugs in the endogenous depressions since 1967. (1982) (3)
- The current status of biological criteria for classifying the depressive disorders and predicting responses to treatment. (1974) (3)
- Adolf Wölfli: Draftsman, Writer, Poet, Composer (1998) (2)
- Neuropharmacological studies of mood disorders. (1969) (2)
- Enhanced signal transduction by adenylate cyclase following elicitation of the relaxation response: Preliminary findings (1990) (2)
- Catecholamines in affective disorders. (1975) (2)
- Preliminary findings on the effects of amitriptyline on norepinephrine-H3 metabolism in rat brain. (1969) (2)
- Acute and delayed effects of adrenocorticotropic hormone on dopamine activity in man (1994) (2)
- Neuropsychopharmacology and the affective disorders. (Third of three parts) (1969) (2)
- MHPG AS A PREDICTOR OF CLINICAL RESPONSE TO FLUOXETINE (1992) (1)
- Proceedings: Comparative properties of soluble and particulate catechol-O-methyl transferase from rat red blood cell: preliminary observations. (1974) (1)
- Proceedings: Norepinephrine metabolism in subtypes of depressive disorders. (1974) (1)
- Neuropsychopharmacology and the affective disorders. (First of three parts). (1969) (1)
- Norepinephrine metabolism in affective disorders (1972) (1)
- Neuropsychopharmacology and the affective disorders (second of three parts). (1969) (1)
- Comparative properties of soluble and particulate catechol-O-methyl transferases from rat red blood cells: preliminary observations. (1974) (1)
- The Effects of Unblocked Heroin upon Catecholamine Metabolism Preliminary Findings (1979) (1)
- Psychoanalytic Perspectives on Art, vol. 3 (1991) (1)
- Effect of cortical spreading depression on norepinephrine-H3 metabolism in brain stem (1968) (1)
- Noradrenergic activity during the transition from depression to mania. (1971) (1)
- Clozapine limits alcohol drinking in hamsters: Implications for treatment of schizophrenia (2003) (1)
- The catecholamine hypothesis (2020) (0)
- EFFECTS OF FLUOXETINE & DESIPRAMINE ON PLATELET IMIPRAMINE BINDING IN MAJOR DEPRESSION (1992) (0)
- Carnival of the Harlequin (2016) (0)
- Dr. Schildkraut and Colleagues Reply (1995) (0)
- Psychoanalytic Perspectives on Art, vol.2 (1989) (0)
- Book Reviews (1979) (0)
- Editorial: Software survey section (1990) (0)
- Pictures at an Exhibition: Selected Essays on Art and Art Therapy (1990) (0)
- CREACTIVITY AND MENTAL ILLNESS. AUTHOR'S REPLIES (1995) (0)
- Biochemistry of Mental Disorders—Technical Report Series No. 427 (1971) (0)
- Antidepressant drugs. (1966) (0)
- Psychopharmacology of biogenic amines in depressions. (1975) (0)
- BOOK REVIEWS (2005) (0)
- EFFECTS OF FLUOXETINE AND DESIPRAMINE ON URINARY CATECHOLAMINE AND METABOLITE EXCRETION IN MAJOR DEPRESSION (1992) (0)
- Platelet monoamine oxidase activity schizophrenia and deficit syndrome (1995) (0)
- Chemotherapy in Psychiatry (1978) (0)
- _tdation. It is tl METABOLISM OF INTRACISTERNALLY ADMINISTERED in_themeta- ( SEROTONIN 1N RAT BRAIN (1978) (0)
- Henri Temianka Correspondence; (schildkraut) (1961) (0)
This paper list is powered by the following services:
